LLY

749.85

+1.61%↑

JNJ

177.08

-0.6%↓

ABBV

210.45

+0.22%↑

UNH

348.61

+8.84%↑

NVO

54.26

-0.09%↓

LLY

749.85

+1.61%↑

JNJ

177.08

-0.6%↓

ABBV

210.45

+0.22%↑

UNH

348.61

+8.84%↑

NVO

54.26

-0.09%↓

LLY

749.85

+1.61%↑

JNJ

177.08

-0.6%↓

ABBV

210.45

+0.22%↑

UNH

348.61

+8.84%↑

NVO

54.26

-0.09%↓

LLY

749.85

+1.61%↑

JNJ

177.08

-0.6%↓

ABBV

210.45

+0.22%↑

UNH

348.61

+8.84%↑

NVO

54.26

-0.09%↓

LLY

749.85

+1.61%↑

JNJ

177.08

-0.6%↓

ABBV

210.45

+0.22%↑

UNH

348.61

+8.84%↑

NVO

54.26

-0.09%↓

Search

NeoGenomics Inc

Затворен

7.87 -0.76

Преглед

Промяна на цената на акция

24 ч

Текуща

Минимум

7.8

Максимум

7.95

Ключови измерители

By Trading Economics

Приходи

-19M

-45M

Продажби

13M

181M

Марж на печалбата

-24.867

Служители

2,200

EBITDA

-41M

-48M

Препоръки

By TipRanks

Препоръки

Купи

12-месечна прогноза

+30.26% upside

Дивиденти

By Dow Jones

Следващи печалби

4.11.2025 г.

Пазарни показатели

By TradingEconomics

Пазарна капитализация

303M

1.1B

Предишно отваряне

8.63

Предишно затваряне

7.87

Техническа оценка

By Trading Central

Увереност

Very Strong Bearish Evidence

NeoGenomics Inc Графика

Миналото представяне не гарантира бъдещи резултати.

Свързани новини

8.09.2025 г., 17:01 ч. UTC

Значими двигатели на пазара

Eightco Holdings Stock Surges as Dan Ives Joins Board Amid Crypto Push

8.09.2025 г., 17:01 ч. UTC

Значими двигатели на пазара

Tron Shares Rise After New Investment From Bravemorning

8.09.2025 г., 15:14 ч. UTC

Придобивния, сливания и поглъщания

CoinShares to Go Public by Merging With SPAC

8.09.2025 г., 13:58 ч. UTC

Значими двигатели на пазара

Forward Industries Shares Jump After Private Investment for Solana

5.09.2025 г., 14:58 ч. UTC

Значими двигатели на пазара

Pineapple Financial Shares Rise After $100 Million Private Placement Closes

2.09.2025 г., 16:52 ч. UTC

Значими двигатели на пазара

CleanCore Solutions Shares Drop After $175 Million Private Investment

8.09.2025 г., 16:16 ч. UTC

Печалби

Strategy Stock May Not Ever Make It Into the S&P 500 Index -- Barrons.com

8.09.2025 г., 08:17 ч. UTC

Пазарно говорене

Global Forex and Fixed Income Roundup: Market Talk

8.09.2025 г., 08:17 ч. UTC

Пазарно говорене

Bitcoin Falls as Traders Eye U.S. Inflation Data -- Market Talk

5.09.2025 г., 16:39 ч. UTC

Придобивния, сливания и поглъщания

Yorkville Acquisition: Commencing at Market Open on Sept 8, Common Stk Will Trade on Nasdaq Under New Ticker Symbol 'MCGA' >YORK

5.09.2025 г., 16:39 ч. UTC

Придобивния, сливания и поглъщания

Yorkville Acquisition: Will Be Renamed to Trump Media Group CRO Strategy Upon Closing of Combination Between Yorkville, Trump Media & Technology Group Corp. and Crypto.com >YORK

5.09.2025 г., 16:39 ч. UTC

Придобивния, сливания и поглъщания

Yorkville Acquisition Corp.: Announces Ticker Symbol Change to 'MCGA' Ahead of Trump Media Group CRO Strategy, Inc. Listing

5.09.2025 г., 16:39 ч. UTC

Придобивния, сливания и поглъщания

Yorkville Acquisition: Outstanding Publicly Traded Units and Warrants Will Trade on Nasdaq Under New Ticker Symbols 'MCGAU' and 'MCGAW', Respectively >YORK

5.09.2025 г., 14:43 ч. UTC

Значими двигатели на пазара

Pineapple Financial Shares Rise After $100M Private Placement Closes

5.09.2025 г., 14:06 ч. UTC

Придобивния, сливания и поглъщания

Trump Media to Buy Cryptocurrency From Crypto.com In Deal Worth $104.7M

5.09.2025 г., 07:50 ч. UTC

Пазарно говорене

Global Forex and Fixed Income Roundup: Market Talk

5.09.2025 г., 07:50 ч. UTC

Пазарно говорене

Bitcoin Rises to One-Week High Before U.S. Jobs Data -- Market Talk

4.09.2025 г., 08:03 ч. UTC

Пазарно говорене

Bitcoin Becoming More Affected by U.S. Data -- Market Talk

4.09.2025 г., 07:45 ч. UTC

Пазарно говорене

Bitcoin Edges Lower as Traders Eye U.S. Jobs Data, Tariff Uncertainty -- Market Talk

3.09.2025 г., 09:18 ч. UTC

Пазарно говорене

Bitcoin Falls as Bond Market Selloff Dents Sentiment -- Market Talk

2.09.2025 г., 16:37 ч. UTC

Значими двигатели на пазара

CleanCore Solutions Shares Drop After $175M Private Investment

2.09.2025 г., 13:25 ч. UTC

Придобивния, сливания и поглъщания

PharmaCyte Biotech Increased Stake in TNF by an Additional $3M >PMCB

2.09.2025 г., 13:24 ч. UTC

Придобивния, сливания и поглъщания

PharmaCyte Biotech Increases Stake in TNF Pharmaceuticals Around Recent License for Breakthrough Light Speed Computing Platform for Use in Cryptocurrency Applications

2.09.2025 г., 11:04 ч. UTC

Придобивния, сливания и поглъщания

Sharps Technology Acquires Over 2M SOL, the Native Asset of Solana

2.09.2025 г., 07:31 ч. UTC

Пазарно говорене

Bitcoin Lifted by Fed Rate Cut Bets, Metaplanet Purchases -- Market Talk

1.09.2025 г., 08:20 ч. UTC

Пазарно говорене

Tech, Media & Telecom Roundup: Market Talk

1.09.2025 г., 07:07 ч. UTC

Пазарно говорене

Bitcoin Falls to 2-Month Low After Tech Slump -- Market Talk

29.08.2025 г., 07:16 ч. UTC

Пазарно говорене

Bitcoin Falls as Traders Digest Waller Remarks, Await PCE Data -- Market Talk

29.08.2025 г., 07:16 ч. UTC

Пазарно говорене

Global Forex and Fixed Income Roundup: Market Talk

28.08.2025 г., 08:37 ч. UTC

Пазарно говорене

Bitcoin ETFs See Pickup in Demand -- Market Talk

Сравнение с други в отрасъла

Ценова промяна

NeoGenomics Inc Прогноза

Ценова цел

By TipRanks

30.26% нагоре

12-месечна прогноза

Среден 10.33 USD  30.26%

Висок 14 USD

Нисък 8 USD

Според 11 анализатори от Wall Street, предложили 12-месечна ценова цел за NeoGenomics Inc през последните три месеца.

Консенсусна оценка

By TipRanks

Купи

11 ratings

5

Купи

6

Задържане

0

Продай

Техническа оценка

By Trading Central

7.7 / 10.27Подкрепа & съпротива

Краткосрочен план

Very Strong Bearish Evidence

Средносрочен план

Bearish Evidence

Дългосрочен план

Bearish Evidence

Финанси

Продажбени и админисративни разходи

Оперативни разходи

Печалба преди облагане с данъци

Продажби

Разходи за продажби

Брутна печалба от продажби

Разходи за лихви по дълг

EBITDA

Оперативна печалба

$

Относно NeoGenomics Inc

NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States and the United Kingdom. It operates through Clinical Services and Advanced Diagnostics segments. The company offers testing services to hospitals, academic centers, pathologists, oncologists, clinicians, pharmaceutical companies, and clinical laboratories. It also provides cytogenetics testing services to study normal and abnormal chromosomes and their relationship to diseases; fluorescence in-situ hybridization testing services that focus on detecting and locating the presence or absence of specific DNA sequences and genes on chromosomes; flow cytometry testing services to measure the characteristics of cell populations; and immunohistochemistry and digital imaging testing services to localize cellular proteins in tissue section, as well as to allow clients to visualize scanned slides, and perform quantitative analysis for various stains. In addition, the company also provides molecular testing services, which focus on the analysis of DNA and/or RNA, and the structure and function of genes at the molecular level; morphologic analysis, which is the process of analyzing cells under the microscope by a pathologist for the purpose of diagnosis; and testing services in support of its pharmaceutical clients' oncology programs covering discovery and commercialization. NeoGenomics, Inc. was founded in 2001 and is headquartered in Fort Myers, Florida.
help-icon Live chat